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ABSTRACT
The aim of this study was to determine if Eurycoma longifolia in combination with maca root
could be effective in treating women with hypoactive sexual desire disorder. Using a
randomized, placebo-controlled, cross-over, case study design we evaluated the hypothesis that
E. longifolia and maca root (3400 total mg/day) supplementation by premenopausal women with
hypoactive sexual desire disorder would improve mood, libido, overall quality of life, muscular
strength, and aerobic capacity. E. longifolia and maca root supplementation had little effect on
the measured variables. It did not improve overall well-being and libido but had a slight effect on
decreasing feelings of tension and anxiety, as well as increasing feelings of energy and physical
appearance. E. longifolia and maca root supplementation did not elicit positive changes in
muscular strength or aerobic capacity. Further investigation using a larger sample size may
evaluate the aphrodisiac properties of E. longifolia and maca root.
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Effects of Eurycoma longifolia and Maca Root on Libido and Mood in Premenopausal Women
with Hypoactive Sexual Desire Disorder: A Case Study Design
Introduction
In the presence of low testosterone, men and women may experience hypoactive sexual
desire disorder (HSDD), which is characterized as a lack or absence of sexual fantasies and
desire for sexual activity (Leiblum, Koochaki, Rodenberg, Barton, & Rosen, 2006). HSDD
affects a higher percentage of women than men, and it affects women at all reproductive stages
(Sowers, Beebe, McConnell, Randolph, & Jannausch, 2001). HSDD is prevalent among younger
surgically postmenopausal women (26%) but can also be found in premenopausal women (14%)
and naturally menopausal women (9%) (Sowers et al., 2001). Many women experience distress
due to the lack or decline of sexual desire, which may affect personal relationships. Low
testosterone levels in women may have negative impacts on body composition (Gasperino,
1995), bone health (Brincat et al., 1985), libido (Goldstat, Briganti, Tran, Wolfe, & Davis,
2003), skin appearance (Ng Tang Fui et al., 2013), and overall health (Pluchino et al., 2013).
Many of the above problems lead to a further loss of sexual interest, as women experience
decreased self-esteem based on their thoughts of poor personal physical appearance.
Dietary and herbal supplementation is an alternative to pharmaceutical products such as
the transdermal patches and gels. One herbal supplement, Eurycoma longifolia, has been of great
interest with research studies conducted in animals (Ang & Sim, 1997, 1998) and humans
(Hamzah & Yusof, 2003; Henkel et al., 2014; Muhamad, Chen, Ooi, & Abdullah, 2009;
Muhamad, Chen, Ooi, Abdullah, & Lam, 2010; Sarina, Zaiton, Aminudin, Nor, & Azizol, 2009;
Tambi, Imran, & Henkel, 2012). The roots of E. longifolia are of particular interest, as chemical
compounds have been extracted from the roots. These compounds have anti-tumor promoting
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and anti-parasitic properties, as well as the ability to increase circulating testosterone (Bhat &
Karim, 2010). The use of an E. longifolia supplementation in both elderly men and women (5772 years of age) promotes increases in muscular strength and circulating testosterone (Henkel et
al., 2014). Women experienced a 49% increase in total testosterone (0.35 ± 0.17 to 0.52 ± 0.30
ng/mL) and a 32% increase in free testosterone (0.50 ± 0.24 to 1.11 ± 0.66 pg/mL). Men also
experienced a 15% significant increase in total testosterone (3.84 ± 0.79 to 4.42 ± 1.15 ng/mL)
and a 61% increase free testosterone (5.20 ± 1.60 to 8.38 ± 2.18 pg/mL).
Additionally, maca root, has shown the potential to be an aphrodisiac in animals (Zheng
et al., 2000) and humans (Brooks et al., 2008). Maca, or Lepidium meyenii, is a plant indigenous
to the Andes Mountains, and extracts of the root have been used to improve sexual function for
centuries (Shin, Lee, Yang, Lim, & Ernst, 2010). Phytosterols or phytoestrogens, which are two
compounds found in maca, may be the mechanism for improving sexual function (Shin et al.,
2010). In fact, when postmenopausal women were treated with 3.5g per day for 6 weeks of
powdered maca, sexual dysfunction was reduced and psychological symptoms were improved
(Brooks et al., 2008).
To date, it is has not been determined if premenopausal women with hypoactive sexual
desire disorder can supplement with E. longifolia and maca root with positive outcomes. Since
14% of premenopausal women suffer from HSDD, understanding the effects of an herbal
supplement may be a novel way to treat HSDD in women. Therefore, the purpose of this study
was to determine the effect of E. longifolia and maca root on subjective feelings and libido in
addition to muscle strength and aerobic capacity in premenopausal women. We hypothesized
that supplementation of E. longifolia and maca root would improve subjective feelings such as
mood, libido, and overall quality of life. The improved subjective feeling would be indicated via
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scores on the psychological general well-being index and the brief profile of female sexual
function. Secondarily, we hypothesized that a potential elevation in testosterone noted with
treatment may lead to an increase in aerobic capacity (via treadmill testing) and muscle strength
(via grip strength).
Methodology
Subjects
Three women with hypoactive sexual desire disorder were recruited to participate in this
study. The study was exploratory in nature, as no studies have examined the effects of a
botanical agent on premenopausal women with HSDD. Therefore, we had no empirical data to
use in calculating a sample size based on power analysis. Moreover, at this stage of investigation
the qualitative outcomes (subjective feelings of mood, quality of life, and libido) are of greater
importance than potential quantitative outcomes (muscle strength and aerobic capacity).
Women were screened into the study using the brief profile of female sexual function. A
score of less than 20 out of a possible 35 was needed to be classified as having hypoactive sexual
desire disorder. Subjects needed to be in good overall health, not current smokers, and without a
history of cardiovascular or metabolic disease. Subjects were not using hormonal replacement
therapy (including birth control) or dietary supplements designed to increase testosterone.
Subjects were not pregnant or nursing and a urine pregnancy test was administered to all
subjects. Subjects were not diagnosed with depression or had a history of sleep disorders, as
these conditions are known to negatively impact testosterone levels (Andersen & Tufik, 2008;
Carnahan & Perry, 2004). Subjects were in a stable, sexually active relationship for a minimum
of the past one year. Health history, medication and dietary supplement usage, and physical
activity questionnaires were completed by all subjects and reviewed by an investigator to
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determine eligibility. Subjects were informed of all procedures, potential risks, and benefits
associated with the study through both verbal and written form. The University Institutional
Review Board for Human Subject Research reviewed and approved the study procedures.
Initial Laboratory Visit: Screening Visit
During the initial lab visit, subjects completed all necessary paperwork, inclusive of the
informed consent, health history and physical activity questionnaires. Subjects’ heart rate, blood
pressure, height, weight, waist, and hip circumference were measured and recorded. Subjects
were given a urine pregnancy test. Subjects practiced the hand grip strength protocol in order to
be familiarized with the protocol on test visits. They walked on a treadmill for 3-6 mins in order
to be familiarized to the treadmill to be used to in the test visits. Subjects then scheduled their
subsequent lab visits, as well as received all study instructions and a daily diary to complete.
Supplementation
Following the above assessments on day 1, subjects were assigned in a double blind
manner, using a crossover design, to both the supplement and placebo. Each condition (two
capsules twice daily) was ingested daily for a period of 28 days. The supplementation periods
began at the start of the subject’s menstrual cycle (within the first 3 days). Supplementation
consisted of 400 mg of a standardized water-soluble extract of E. longifolia with 3g of maca root.
The supplement was provided to each subject in a capsule bottle and produced under Good
Manufacturing Practices by a dietary supplement manufacturer. Capsules were of similar
appearance and provided to subjects in unlabeled bottles. Subject compliance to supplement
intake was determined based on remaining capsules left in the bottles upon return.
Test Visit Procedures
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Following the screening visit, subjects returned to the lab (before supplementation and
after 28 days of supplementation for each condition) to complete the assessments indicated
below. On each occasion, subjects reported to the lab in a 10-hour overnight fasted state without
having consumed alcohol or caffeine within the past 24 hours. Subjects were instructed to obtain
at least 7 hours of sleep during the night prior to testing. Subjects did not perform strenuous
physical exercise within the past 24 hours.
Subjects reported to the lab in the morning hours (i.e., 6:00 – 9:00am) and the time of day
was matched for each lab visit. On each visit, subjects completed the psychological general wellbeing index, the brief profile of female sexual function, another general questionnaire, hand grip
strength test, and a maximal graded exercise test.
Psychological General Well-Being Index
The first questionnaire that was completed during each visit was the psychological
general well-being index (PGWBI). The PGWBI is a self-administered quality of life assessment
(22 total items), which has been validated (Dupuy, 1984). Subjects rated feelings of anxiety,
depressed mood, positive well-being, self-control, general health, and vitality. The PGWBI can
be found in appendix A.
The Brief Profile of Female Sexual Function
The second questionnaire administered is referred to as the brief profile of female sexual
function (B-PFSF). The questionnaire scored sexual desire, arousal, orgasm, and problems
affecting sexual function. The B-PFSF was designed to be a self-administered screening tool and
is a valid tool in discriminating between women with or without hypoactive sexual desire
disorder (Rust et al., 2007). According to women, the B-PFSF is easy to fill out and covers
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relevant aspects of sexual function. Scores can be from 0 – 35 and any score below 20 was
classified as having HSDD. This form can be found in appendix B.
Weekly Diary
The subjects were instructed to record their subjective feeling of energy levels, libido,
and mental outlook using a Likert scale. There was also a space included for the subjects to
provide comments as needed. This form was created to evaluate subjects’ subjective feelings
over the course of supplementation. The weekly diary can be found in appendix C.
Questionnaire
Due to the potential influence of E. Longifolia and maca root on subjective feelings,
subjects completed a questionnaire on the morning of each test day. Using a scale of 1-10, with 1
representing the lowest rating and 10 representing the highest rating, subjects rated a number of
variables pertaining to overall health with regards to how they felt over the past four weeks. The
questionnaire can be found in appendix D.
Hand Grip Strength Test
For the hand grip strength test, the participant was instructed to take a standing position
with arms at their side, not touching their body. The elbow was slightly bent. The test was
conducted using the dominant hand. The subject squeezed the dynamometer with as much force
as possible for approximately 3 s. Three trials were conducted with 30 s of rest between each
trial to avoid the effects of muscle fatigue. If the difference between any two measures is more
than 3 kg, another trial was conducted. In this case, the outlier was not used in data analysis.
Aerobic Fitness Test
A maximal graded exercise test (GXT) was conducted using a treadmill. The test began
at a speed of 3.0 mph with 0% grade. It progressed either in speed or grade every two mins until
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fatigue. The test continued until one of the following occurred, in accordance with the guidelines
of the American College of Sports Medicine (ACSM): subject could no longer continue due to
fatigue and requests to stop, or subject showed signs/symptoms that indicated the test is stopped.
These include signs of distress beyond what is typical during acute exercise bouts (e.g., unusual
and rapid breathing patterns, severe shortness of breath, profuse sweating, cold and clammy
skin), lightheadedness or dizziness, or moderate to severe chest pain. Heart rate was monitored
during testing using a heart rate monitor. The Borg scale of exertion was used to allow subjects
to indicate their level of perceived work. Subjects were allowed an active cool-down period (e.g.,
slow speed walking) for several minutes until their heart rate falls below 120 beats per min or
stabilizes. We have used this same protocol in recent studies at it works well for the intended
purpose. Both sedentary and active individuals can use this same protocol, as the initial workload
is simply a slow walk. The sedentary individuals simply become fatigued earlier than the active
individuals.
Dietary Intake and Physical Activity
Subjects were instructed to consume their usual diet and to record dietary intake during
the 48 hours prior to each test day. Diets were examined for macro- and micro-nutrient content
using food analysis software, as micronutrient and macronutrient intake may affect hormone
levels. Physical activity should have remained similar for subjects throughout the study.
Results and Discussion
For this study, we had initially planned on recruiting a total of 15 subjects. However,
there were issues recruiting subjects, as well as keeping subject enrolled for the duration of the
study. Three subjects successfully completed all aspects of the study, and therefore the results of
the three subjects are presented below using a case study format.
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Subject 1
One subject was a 30-year-old Caucasian female, who has been married for 6 years. She
is 168.5 cm tall, weighs 82.6 kg, has a resting heart rate of 72 beats per min, and her resting
blood pressure was 132/94 mmHg. She had no history of cardiovascular disease, metabolic
disease, depression, anxiety, or sleep disorders. She was in a sexually active relationship but not
currently using any birth control, nor was she pregnant or nursing. She is not a current smoker.
For aerobic training, she has been completing two 45 mins sessions per week with a selfdescribed intensity of “somewhat hard” for a total of 10 years. She does not partake in
recreational sports or in anaerobic training.
The psychological general well-being index (PGWBI) was used to assess changes in
quality of life with supplementation. For the placebo condition, the score increased 13 points
while the score decreased 6 points for the E. longifolia and maca root (EL+MR) condition,
(Figure 1). The decrease in overall well-being does not agree with findings of previous research
as both E. longifolia and aca root have been shown to increase overall well-being (Brooks et al.,
2008; Talbott, Talbott, George, & Pugh, 2013). The age of the subject is lower than the age of
subject in the previous research, so the difference in age may be the reason the subject did not
respond positively to supplementation.
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Figure 1. Psychological General Well Being Index for Subject 1
The brief profile of female sexual function (B-PFSF) was used to determine sexual
desire, arousal, orgasm, and problems affecting sexual function after supplementation. For the
placebo condition, the B-PFSF score increase by 2 points while it dropped by 3 points for the
EL+MR condition (Figure 2). These results are similar to those seen in the PGWBI. The
decrease in libido does not agree with findings of previous research as both E. longifolia and
maca root have been shown to increase libido (Brooks et al., 2008; Talbott et al., 2013). The
results from the PGWBI and the B-PFSF show that EL+MR supplementation did not have a
positive effect in this subject. One reason this subject may have not seen an increase in either the
PGWBI or the B-PFSF is the stressors from completing exams and other projects while enrolled
in college courses. The compounds in the EL+MR supplement may not have able to influence
libido and overall well-being because the potential negative effects of stress in the subject.
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Figure 2. Brief Profile of Female Sexual Function for Subject 1
The weekly diary was used to evaluate subjects’ subjective feelings of energy levels,
libido, and mental outlook over the course of supplementation. For the subject, the diary energy
mean, the diary libido mean, and the diary outlook mean were higher during the placebo
condition than during the EL+MR condition (Figure 3). The results from the weekly dairy
follows the same trend as the results from the PGWBI and the B-PFSF.
8
7
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Placebo

4

EL/MR

3
2
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0
Diary Energy Mean

Diary Libido Mean

Diary Outlook mean

Figure 3. Weekly Diary Means for Subject 1
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The general questionnaire was used to determine changes in a number of variables
pertaining to overall health with supplementation. In regards to the general questionnaire, the
subject noted no changes in alertness for either of the conditions with a rating of 8 at each time
point (Table 1). For energy, there were increases seen for the placebo condition and the EL+MR
condition. In terms of aggressiveness, this subject experience an increase in the placebo
condition, but ratings did not change for the EL+MR condition. Increases in vitality were
observed for the EL+MR condition while the ratings remained unchanged for the placebo
condition. The only changed noted by the subject regarding libido was seen in the EL+MR
condition. The lowest rating for sleep quality was seen at the end of the EL+MR condition.
Mental outlook decreased for the EL+MR condition and remained unchanged for the placebo
condition. Mental clarity was similar to mental outlook as ratings decreased in the EL+MR
condition and remained unchanged in the placebo condition. This subject rated physical
appearance highest in the EL+MR condition and did not note any changes with the placebo
condition. Rating of subjective muscle strength increased following placebo supplementation but
decreased following the EL+MR condition. Lastly, she had no change in ratings of tension and
anxiety in the placebo condition, and noted an increase with the EL+MR condition. Again, these
results are similar to those found with the PGWBI, the B-PFSF, and the weekly dairy.
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Table 1
General Questionnaire for Subject 1
Placebo

EL/MR

Pre
Alertness
Energy

Aggressiveness
Vitality
Libido
Sleep Quality
Mental Outlook
Mental Clarity
Physical Appearance
Muscle Strength
Muscle Endurance
Tension/Anxiety

Post
8
5
3
6
5
6
8
8
6
5
5
4

Pre
8
6
6
6
5
5
8
8
6
8
5
4

Post
8
6
6
6
5
5
8
8
6
8
5
4

8
8
6
7
4
4
6
7
7
7
7
5

The hand grip strength test was used to assess changes in muscular strength with
supplementation. Muscle strength using the hand grip strength test increased by 1 kg after the
placebo condition by reduced by 2 kg after the EL+MR condition (Figure 4). From these
findings, it appears that E. longifolia had no influenced on muscular strength. E. longifolia has
been shown to increase muscle strength in previous research, whereas maca root has been shown
to only influence psychological well-being and sexual dysfunction and not hormone levels
(Brooks et al., 2008; Henkel et al., 2014).
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Figure 4. Hand Grip Strength for Subject 1
The aerobic fitness test was used to assess changes in aerobic capacity with
supplementation. Neither the placebo or supplementation condition had a positive impact on total
treadmill time (Figure 5). Aerobic capacity was not affected by supplementation, which is
similar to what is seen with the hand grip strength test.
14
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Minutes
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8
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Post
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2
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EL/MR

Placebo

Figure 5. Treadmill Time to Fatigue for Subject 1
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Subject 2
A second subject was a 31-year-old African American female, who has been in a
relationship for a year and a half. She is 163.5 cm tall, weighs 81.2 kg, has a resting heart rate of
78 beats per min, and her resting blood pressure was 113/76 mmHg. She had no history of
cardiovascular disease, metabolic disease, depression, anxiety, or sleep disorders. She was in a
sexually active relationship but not currently using any birth control, nor was she pregnant or
nursing. She is not a current smoker and has never smoked in the past. This subject has been
performing light intensity aerobic exercise 5 days a week lasting 30 mins for 2 years. She has no
history of organized or recreational sports or anaerobic training.
The psychological general well-being index (PGWBI) was used to assess changes in
quality of life with supplementation. For the placebo condition, the score increased 12 points
while the score increased 2 points for the EL+MR condition, (Figure 6). The increase in overall
well-being is similar to previous research but not the same magnitude (Brooks et al., 2008;
Talbott et al., 2013).
120
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Figure 6. Psychological General Well Being Index for Subject 2
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The brief profile of female sexual function (B-PFSF) was used to determine sexual
desire, arousal, orgasm, and problems affecting sexual function after supplementation. For the
placebo condition, the B-PFSF score did not change while it increased 4 points for the EL+MR
condition (Figure 7). The increase in libido is similar to previous research but not the same
magnitude (Brooks et al., 2008; Talbott et al., 2013). The results from the PGWBI and the BPFSF show that EL+MR supplementation had a greater effect for this subject’s libido than
overall well-being.
35
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Figure 7. Brief Profile of Female Sexual Function for Subject 2
The weekly diary was used to evaluate subjects’ subjective feelings of energy levels,
libido, and mental outlook over the course of supplementation. For the subject, the diary energy
mean, the diary libido mean, and the diary outlook mean were higher during the EL+MR
condition than during the placebo condition (Figure 8). The results from the weekly diary show
that the EL+MR condition had a positive effect for the subjective feelings of energy, libido and
outlook, which is similar to previous research (Brooks et al., 2008; Talbott et al., 2013). The
weekly dairy strengthened the case that the EL+MR condition had a positive effect for the
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subject’s libido as both the weekly diary and B-PFSF have the same trends of higher libido with
EL+MR supplementation.
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Figure 8. Weekly Diary Means for Subject 2
The general questionnaire was used to determine changes in a number of variables
pertaining to overall health with supplementation. In regards to the general questionnaire, this
subject noted a change an increase in alertness for the placebo condition, but there were no
changes observed for the EL+MR condition (Table 2). For this subject, energy ratings increased
for the EL+MR condition and the placebo, but the placebo condition saw a greater increase. With
aggressiveness, she experienced an increase in the EL+MR condition but saw no change in the
placebo condition. Vitality ratings increased the same amount for the placebo condition and the
EL+MR condition. This subject noted the increase in libido for the placebo condition but
remained unchanged for the EL+MR condition. As with libido, sleep quality had the largest
increase in the placebo condition. Similar increases were noted by this subject in mental outlook
and mental clarity in the placebo condition. As for physical appearance, the subject noted no
change in the EL+MR condition. As with vitality ratings, subjective muscle strength increased
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the same amount for the placebo condition and the EL+MR condition. Subjective muscle
endurance increased in the placebo condition but not the EL+MR condition. Lastly, ratings of
tension and anxiety decreased in the EL+MR condition. The slight decrease in tension and
anxiety is similar to previous research (Brooks et al., 2008; Talbott et al., 2013).
Table 2
General Questionnaire for Subject 2
Placebo
Pre
Alertness
Energy

Aggressiveness
Vitality
Libido
Sleep Quality
Mental Outlook
Mental Clarity
Physical Appearance
Muscle Strength
Muscle Endurance
Tension/Anxiety

EL/MR
Pre

Post
7
6
5
5
5
4
6
6
7
5
5
2

8
8
5
7
9
9
9
9
10
6
6
2

Post
8
8
5
7
9
9
9
9
10
6
6
2

8
9
8
9
9
8
9
9
10
7
6
1

The hand grip strength test was used to assess changes in muscular strength with
supplementation. Muscle strength using the hand grip strength test did not change after the
placebo condition by increased by 1 kg after the EL+MR condition (Figure 9). There was little
change in muscle strength and aerobic capacity. From these findings, it appears that the maca
root had an influenced the changes in subjective feelings and not the E. longifolia. E. longifolia
has been shown to increase muscle strength in previous research, whereas maca root has been
shown to only influence psychological well-being and sexual dysfunction and not hormone
levels (Brooks et al., 2008; Henkel et al., 2014). It is possible that E. longifolia had a small,
positive effect on testosterone as grip strength did have a small increase with EL+MR
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supplementation. However, it would be unlikely that a small increase in testosterone would
positively influence libido and overall well-being. This subject appeared to respond more
favorable to compounds found in the maca root extract.
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Figure 9. Hand Grip Strength for Subject 2
The aerobic fitness test was used to assess changes in aerobic capacity with
supplementation. The subject experienced an increase in total treadmill time from the placebo
condition but a decrease after the EL+MR condition (Figure 10). The EL+MR condition did not
have a positive effect on aerobic capacity as expected.
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Figure 10. Treadmill Time to Fatigue for Subject 2
Subject 3
The third subject was a 47-year-old African American female, who has been married for
4 years. She is 158 cm tall, weighs 70.6 kg, has a resting heart rate of 93 beats per minute, and
her resting blood pressure was 118/82 mmHg. She had no history of cardiovascular disease,
metabolic disease, depression, anxiety, or sleep disorders. She was in a sexually active
relationship but not currently using any birth control, nor is she pregnant or nursing. She is not a
current smoker and has never smoked in the past. This subject has been performing light
intensity aerobic exercise 5 days a week lasting 10 mins, for 10 or more years. She has no history
of organized or recreational sports or anaerobic training.
The psychological general well-being index (PGWBI) was used to assess changes in
quality of life with supplementation. The subject experienced slight decreases in the PGWBI for
both conditions (Figure 11). The decrease in overall well-being does not agree with findings of
previous research as both E. longifolia and maca root have been shown to increase overall wellbeing (Brooks et al., 2008; Talbott et al., 2013).
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Figure 11. Psychological General Well Being Index for Subject 3
The brief profile of female sexual function (B-PFSF) was used to determine sexual
desire, arousal, orgasm, and problems affecting sexual function after supplementation. For the
placebo condition, the B-PFSF score increased 4 points while it decreased 5 points for the
EL+MR condition (Figure 12). The decrease in libido does not agree with findings of previous
research as both E. longifolia and maca root have been shown to increase libido (Brooks et al.,
2008; Talbott et al., 2013). The results from the B-PFSF and the PGWBI indicate that EL+MR
supplementation did not have a positive effect on libido and overall well-being in this subject.
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Figure 12. Brief Profile of Female Sexual Function for Subject 3
The weekly diary was used to evaluate subjects’ subjective feelings of energy levels,
libido, and mental outlook over the course of supplementation. The subject had no change in the
diary energy mean, but the diary libido mean was higher in the EL+MR condition. However the
was the diary outlook mean was lower during the EL+MR condition (Figure 13). The libido
mean from the weekly questionnaire was higher for the EL+MR condition than the placebo
condition, which may indicate that her libido was on average higher during the EL+MR
condition. The EL+MR supplement may have not had a positive effect, as the subject’s energy
levels mental outlook were high before supplementation and therefore no room for improvement.
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Figure 13. Weekly Diary Means for Subject 3
The general questionnaire was used to determine changes in a number of variables
pertaining to overall health with supplementation. From the general questionnaire, alertness,
energy, and vitality ratings were the same for both conditions (Table 3). Mental outlook, mental
clarity, and physical appearance are the same for both conditions. Aggressiveness ratings
decreased in the placebo condition and increased in the E. longifolia and maca root condition.
The subject, for the EL+MR condition, noted an increase in libido. Conversely, libido decreased
in the placebo condition. For sleep quality, the subject noted no change for either condition.
Subjective muscle strength and muscle endurance remained the same for the EL+MR condition
and decreased in the placebo condition. Lastly, this subject noted a noted a decrease in tension
and anxiety for the EL+MR condition, but an increase for the placebo condition. There was a
slight decrease in tension and anxiety, which is similar to previous research (Brooks et al., 2008;
Talbott et al., 2013).
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Table 3
General Questionnaire for Subject 3
Placebo
Pre
Alertness
Energy

Aggressiveness
Vitality
Libido
Sleep Quality
Mental Outlook
Mental Clarity
Physical Appearance
Muscle Strength
Muscle Endurance
Tension/Anxiety

EL/MR
Pre

Post
10
10
8
10
8
6
10
10
10
9
9
0

10
10
7
10
7
6
10
10
10
8
8
1

Post
10
10
7
10
7
6
10
10
10
8
8
1

10
10
8
10
8
6
10
10
10
8
8
0

The hand grip strength test was used to assess changes in muscular strength with
supplementation. Muscle strength using the hand grip strength test did not change after the
placebo condition by increased by 1 kg after the EL+MR condition (Figure 14). Previous
research has shown E. longifolia supplementation can increase muscular strength, as well as have
a positive influence on testosterone levels (Henkel et al., 2014). It is possible that E. longifolia
had a small, positive effect on testosterone as this subject did experience a small increase in grip
strength with EL+MR supplementation. It would be hard to determine if EL+MR
supplementation influenced subjective feelings of libido and overall well-being as many
subjective feelings were given the highest rating before and after EL+MR supplementation. If
there were changes in the subjective feelings, the changes were minimal. This subject did not
appear to respond in a positive or negative manner to the compounds found in the EL+MR
supplement as few changes were observed in outcome variables.
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40
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30
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20
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15
10
5
0
EL/MR

Placebo

Figure 14. Hand Grip Strength for Subject 3
The aerobic fitness test was used to assess changes in aerobic capacity with
supplementation. This subject experienced decreases in total treadmill time across for both the
placebo condition and the EL+MR condition (Figure 15). As with muscle strength, there was
little change in aerobic capacity.
6
5

Minutes

4
Pre

3

Post
2
1
0
EL/MR

Placebo

Figure 15. Treadmill Time to Fatigue for Subject 3
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Further Investigation
The present study was initially designed to include a sample of 15 women. The study will
be continued until an adequate sample of women is included. Testosterone in saliva samples will
be determined using enzyme linked immunosorbent assay (ELISA) procedures. At that time,
statistical analysis will be used to determine any statistical significance between conditions for
all variables. The results from the statistical analysis may support our present findings of the
influence of E. longifolia and maca root supplementation on feelings of tension, anxiety, energy,
and physical appearance. Further investigation will provide more insight on how E. longifolia
and maca root supplementation affects muscle strength, muscle endurance, and testosterone.
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Appendix A
Psychological General Well Being Index
1. How have you been feeling in general during the past month?
In excellent spirits…………………………………………………………………
In very good spirits………………………………………………………………..
In good spirits mostly……………………………………………………………..
I have been up and down in spirits a lot…………………………………………..
In low spirits mostly………………………………………………………………
In very low spirits…………………………………………………………………
2.

1
0

0
1
2
3
4
5

0
1
2
3
4
5

5
4
3
2
1
0

Have you been bothered by nervousness or your “nerves” during
the past month?
Extremely so – to the point where I could not work or take care of things………
Very much so……………………………………………………………………..
Quite a bit…………………………………………………………………………
Some – enough to bother me…………………….……………………………….
A little…………………………………………………………………………….
Not at all…………………………………………………………………………..

6.

2

Have you been in firm control of your behaviour, thoughts, emotions
or feelings during the past month?
Yes, definitely so…………………………………………………………………
Yes, for the most part…………………………………………………………….
Generally so………………………………………………………………………
Not too well……………………………………….……………………………...
No, and I am somewhat disturbed………………………………………………..
No, and I am very disturbed………………………………………………………

5.

3

Did you feel depressed during the past month?
Yes – to the point that I felt like taking my life…………………………………..
Yes – to the point that I did not care about anything……………………………..
Yes – very depressed almost every day…………………………………………..
Yes – quite depressed several times……………………………………….……...
Yes – a little depressed now and then…………………………………………….
No – never felt depressed at all……………………………………………………

4.

4

How often were you bothered by any illness, bodily disorder, aches or pains
during the past month?
Every day…………………………………………………………………………
Almost every day…………………………………………………………………
About half of the time…………………………………………………………….
Now and then, but less than half the time………………………………………...
Rarely……………………………………………………………………………..
None of the time…………………………………………………………………..

3.

5

How much energy, pep, or vitality did you have or feel during
the past month?
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0
1
2
3
4
5

Very full of energy – lots of pep………………………………………………….
Fairly energetic most of the time……………………………………………….…
My energy level varied quite a bit………………………………………………...
Generally low in energy or pep………………….…………………………….….
Very low in energy or pep most of the time………………………………………
No energy or pep at all – I felt drained, sapped…………………………………...
7.

3
2
1
0

5
4
3
2
1
0

Were you generally tense or did you feel any tension during the past month?
Yes – extremely tense, most or all of the time…………………………………….
Yes – very tense most of the time………………………………………………..
Not generally tense, but did feel fairly tense several times………………………..
I felt a little tense a few times………………….…………………………………
My general tension level was quite low………………………………………….
I never felt tense or any tension at all……………………………………………..

9.

4

I felt downhearted and blue during the past month.
None of this time…………………………………………………………………
A little of the time……………………………………………….………………..
Some of the time……………………………………………….…………………
A good bit of the time………………….…………………………….…………...
Most of the time…………………………………………………………………..
All of the time………………………………….…………………………………

8.

5

0
1
2
3
4
5

How happy, satisfied, or pleased have you been with your personal life
during the past month?
Extremely happy – could not have been more satisfied or pleased………………
Very happy most of the time……………………………………………………..
Generally satisfied, pleased………………………………………………………
Sometimes fairly happy, sometimes fairly unhappy……………………………..
Generally dissatisfied or unhappy…….………………………………………….
Very dissatisfied or unhappy most or all the time………………………………..

5
4
3
2
1
0

10. Did you feel healthy enough to carry out the things you like to do
or had to do during the past month?
Yes – definitely so………………………………………………..………………
For the most part…………..……………………………………….……………..
Health problems limited me in some important ways……………………………
I was only healthy enough to take care of myself ……………………………..
I needed some help in taking care of myself.…………………………………….
I needed someone to help me with most or all of the things I had to do..………..

5
4
3
2
1
0

11. Have you felt so sad, discouraged, hopeless, or had so many problems
that you wondered if anything was worthwhile during the past month?
Extremely so – to the point that I have just about given up..……..………………
Very much so….…………..……………………………………….……………..
Quite a bit…………………………………………………………………………
Some – enough to bother me……………………………………………………..
A little bit…………………………………..……….…………………………….
Not at all………………………………………………………………....………..
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0
1
2
3
4
5

12. I woke up feeling fresh and rested during the past month.
None of the time…………………………………………....……..………………
A little of the time..………..……………………………………….……………..
Some of the time..…………………………………………………………………
A good bit of the time……………………………………………………………..
Most of the time…...………………………..……….…………………………….
All of the time…………………………………………………………....………..

0
1
2
3
4
5

13. Have you been concerned, worried, or had any fears about your health
during the past month?
Extremely so…..…………………………………………....……..………………
Very much so……..………..……………………………………….…………….
Quite a bit……....…………………………………………………………………
Some, but not a lot….…………………………………………………………….
Practically never......………………………..……….…………………………….
Not at all………………………………………………………………....………..

0
1
2
3
4
5

14. Have you had any reason to wonder if you were losing your mind,
or losing control over the way you act, talk, think, feel or of your
memory during the past month?
Not at all…..…………………………………………....……..………………….
Only a little……..………..……………………………………….……………....
Some – but not enough to be concerned or worried about……………………….
Some and I have been a little concerned…………………………………………
Some and I am quite concerned..…………..……….…………………………….
Yes, very much so and I am very concerned…………………………....………..

5
4
3
2
1
0

15. My daily life was full of things that were interesting to me during
the past month.
None of the time……………………………………....……..…………………...
A little of the time………..……………………………………….……………....
Some of the time………………………………………………………………….
A good bit of the time………………….…………………………………………
Most of the time………………..…………..……….…………………………….
All of the time………………………………………………………....………….

0
1
2
3
4
5

16. Did you feel active, vigorous, or dull, sluggish during the past month?
Very active, vigorous every day……..………………....……..………………….
Mostly active, vigorous – never really dull, sluggish…………….……………....
Fairly active, vigorous – seldom dull, sluggish………….……………………….
Fairly dull, sluggish – seldom active, vigorous..…………………………………
Most dull, sluggish – never really active, vigorous...…………………………….
Very dull, sluggish every day…………………………………………....……….

5
4
3
2
1
0

17. Have you been anxious, worried, or upset during the past month?
Extremely so – to the point of being sick or almost sick……..…………………..
Very much so…...………..……………………………………….……………....
Quite a bit……...………………………………………………………………….
Some – enough to bother me..………….…………………………………………
A little bit……..………………..…………..……….…………………………….
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0
1
2
3
4

Not at all…….………………………………………………………....………….

5

18. I was emotionally stable and sure of myself during the past month.
None of the time……………………………………....……..…………………...
A little of the time………..……………………………………….……………....
Some of the time………………………………………………………………….
A good bit of the time………………….…………………………………………
Most of the time………………..…………..……….…………………………….
All of the time………………………………………………………....………….

0
1
2
3
4
5

19. Did you feel relaxed, at ease or high strung, tight, or keyed-up
during the past month?
Felt relaxed and at ease the whole month……………………..…………………..
Felt relaxed and at ease most of the time………………………….……………....
Generally felt relaxed but at times felt fairly high strung...……………………….
Generally felt high strung but at times felt fairly relaxed…………………………
Felt high strung, tight, or keyed-up most of the time..…………………………….
Felt high strung, tight, or keyed-up the whole month.………………....………….

5
4
3
2
1
0

20. I felt cheerful, lighthearted during the past month.
None of the time……………………………………....……..…………………...
A little of the time………..……………………………………….……………....
Some of the time………………………………………………………………….
A good bit of the time………………….…………………………………………
Most of the time………………..…………..……….…………………………….
All of the time………………………………………………………....………….

0
1
2
3
4
5

21. I felt tired, worn out, used up, or exhausted during the past month.
None of the time……………………………………....……..…………………...
A little of the time………..……………………………………….……………....
Some of the time………………………………………………………………….
A good bit of the time………………….…………………………………………
Most of the time………………..…………..……….…………………………….
All of the time………………………………………………………....………….

5
4
3
2
1
0

22. Have you been under or felt you were under any strain, stress, or pressure
during the past month?
Yes – almost more than I could bear or stand………………..…………………..
Yes – quite a bit of pressure…………..………………………….……………....
Yes, some – more than usual………………………….....……………………….
Yes, some – but about usual……………………………………………………...
Yes – a little………………………………………...…………………………….
Not at all…………………………………………….………………....………….
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Appendix B
The Brief Profile of Female Sexual Function
Below you can see a list of statements regarding thoughts and feelings that were found to be
related to Hypoactive sexual desire disorder (HSDD). Please indicate the extent to which you
agree or disagree with each statement by clicking the corresponding checkbox.

Always
☐
☐
☐
☐
☐
☐
☐

I felt like having sex
I was unhappy about my lack of interest in sex
Getting aroused took forever
I felt sexually numb
I felt disappointed by my lack of interest in sex
I lacked sexual desire
I reached orgasm easily
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☐
☐
☐
☐
☐
☐
☐

Never
☐
☐
☐
☐
☐
☐
☐

☐
☐
☐
☐
☐
☐
☐

☐
☐
☐
☐
☐
☐
☐

Appendix C
Weekly Diary
Directions: This questionnaire asks about your current feelings of the below indicated items.
Therefore, it is important that you focus on how you feel for that particular day. Please make a
vertical line on the horizontal line below which best describes the overall feelings. 0 represents
no feelings or the lowest possible rating. 10 represents extreme feelings or the highest possible
rating.

Day 1
Energy levels (0 = EXTREMELY LOW
1

2

3

4

5

6

7

10 = EXTREMELY HIGH)
8

Libido (0 = EXTREMELY LOW
1

2

3

4

5

9

10

10 = EXTREMELY HIGH)
6

7

8

9

10

Mental outlook (0 = EXTREMELY NEGATIVE
1

2

3

4

5

6

7

8

10 = EXTREMELY POSITIVE)
9

10

Comments:
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Appendix D
Using a rating of 1-10, with 1 representing the lowest rating and 10 representing the highest
rating, please rate the following variables, with consideration of how you felt over the past
TWO WEEKS.
Variable

Rating
(1-10)

Provide Comments as Needed

Alertness
Energy Level
Aggressiveness
Vitality
Libido
Sleep Quality
Mental Outlook and Mood
Mental Clarity
Physical Appearance
Muscle Strength
Muscle Endurance
Tension or Anxiety
Other (provide comments)
CONDITION 1

DAY 1

NAME:
ID:
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Appendix F
Statement of the Problem
Maintaining normal concentrations of hormones, such as testosterone, is important as related
to overall quality of life. Lower than normal concentrations of testosterone can lead to a decline
in metabolism, libido, muscle mass, and bone density. These lower concentrations of testosterone
may also contribute to the increase in fat mass, depression, and erectile dysfunction (Harman,
Metter, Tobin, Pearson, & Blackman, 2001; Schulman et al., 2009). Both men and women can
experience a decrease in testosterone with age (Horstman, Dillon, Urban, & Sheffield-Moore,
2012). In men, testosterone levels remain stable until the age of approximately 40 years, when
testosterone concentrations begin to decline (Harman et al., 2001) and levels can decline by
approximately 50% by the age of 60 years. This decline causes an androgen deficiency, which
can be problematic in older populations (Matsumoto, 2003).
Research shows that women with symptoms of low testosterone can be treated with hormone
replacement therapy with positive outcomes (Pluchino et al., 2013). Up to 43% of women note
having sexual problems, with hypoactive sexual desire disorder being commonly reported
(Laumann, Paik, & Rosen, 1999). Hypoactive sexual desire disorder is defined by disturbances,
decreases or absence in sexual desire, which can be apparent in both women and men (Laumann
et al., 1999) (with more women affected than men). Hypoactive sexual desire disorder in women
can be caused by natural menopause and bilateral oophorectomy (Pluchino et al., 2013).
Experiments have shown that a transdermal patch or spray testosterone (alone or in conjunction
with estrogen) can be effective for women who are characterized as having hypoactive sexual
desire disorder due to natural or surgical menopause (S. R. Davis et al., 2008a; S. Davis et al.,
2008; Simon et al., 2005). Therefore, it is believed that testosterone replacement therapy can
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benefit women who have low concentrations of testosterone and can alleviate the aforementioned
symptoms of low testosterone related specifically to libido. The question remains as to whether
or not non-pharmaceutical agents can prove beneficial to improving libido in women with
hypoactive sexual desire disorder.
Literature Review
The present review is focused on the influence that circulating testosterone has on overall
health and well-being in adults, with a specific emphasis on women. The review begins with a
brief overview of herbal supplements and testosterone. The review also emphasizes the impact of
dietary and herbal supplementation on feelings of well-being.
Overview of Herbal Supplements
Western medicine, which developed from the philosophy and science of Hippocrates
some 2,400 years ago, took an analytical or theoretical approach to medicine (Robson & Baek,
2009). On the other hand, eastern countries such as China dealt with medicine in a much more
applied manner, observing self-experiments and anecdotal reports over hundreds of years.
During the 1st century AD, the Chinese scientist, Shen Nong Ben Cao Jing, began to record
herbal medicines as superior or inferior, as well as their effect on various diseases (Hong, 2004).
Herbal medicines have been used for several hundred years to improve overall health of
individuals (Ackerknecht, 1982; Nunn, 2002).
Indeed, herbal supplementation potentially treats a variety of disorders and diseases such
as cardiovascular disease (Fugh‐Berman, 2000; Yeh, Davis, & Phillips, 2006), prostate disease
(Feifer, Fleshner, & Klotz, 2002; Small et al., 2000), chronic liver disease (Levy, Seeff, &
Lindor, 2004), diabetes (Modak, Dixit, Londhe, Ghaskadbi, & Devasagayam, 2007), and eye
diseases (West, Oren, & Moroi, 2006). There has been a growing interest in using dietary
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supplements in the U.S. over the past forty years. With the potential ability to prevent or treat a
variety of diseases, herbal supplement use has become more common across age ranges, with
approximately 20% of adults reporting use of herbal supplements (Bailey et al., 2011). The
effectiveness of herbal supplementation has been investigated for improving various aspects of
human health, from pregnancy (Smeriglio, Tomaino, & Trombetta, 2014) and obesity
(Greenway & Heber, 2012) to depression (Lee & Ji, 2014) and physical performance (Qureshi,
Naughton, & Petroczi, 2014a). Investigations have also been conducted using herbal
supplements as treatments for a variety of human diseases (Feifer et al., 2002; Levy et al., 2004;
West et al., 2006).
With this growing interest in using herbal supplements, more research has been devoted
to determining the effects of herbal supplementation on specific hormone concentrations
(Bidwell, 2013; George & Henkel, 2014; Qureshi et al., 2014a). Much of this research focuses on
the effects of dietary supplements in the respect to testosterone and growth hormone (Bidwell,
2013; George & Henkel, 2014). Specific herbal and botanical agents may aid the body to
produce these hormones naturally, which may be preferred over taking other medicinal products.
Botanical agents and dietary supplements that have been reported to increase testosterone and
libido include Eurycoma longifolia (Hamzah & Yusof, 2003; Henkel et al., 2014; Muhamad,
Chen, Ooi, & Abdullah, 2009; Muhamad, Chen, Ooi, Abdullah, & Lam, 2010; Sarina, Zaiton,
Aminudin, Nor, & Azizol, 2009; Tambi, Imran, & Henkel, 2012) and D-aspartic acid (Topo,
Soricelli, D’Aniello, Ronsini, & D’Aniello, 2009), respectively. Maca root is another botanical
agent, which has been reported to increase libido, but it does not appear to influence testosterone
levels (Zheng et al., 2000).
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Overview of Testosterone
Testosterone plays an important role in human physiology, as it can affect muscle
growth, muscle strength, and overall well-being and vitality (Finkelstein et al., 2013).
Testosterone is a steroid hormone, which is responsible for the development of male secondary
sexual characteristics (Finkelstein et al., 2013). Testosterone is naturally produced in males
mainly by the Leydig cells located in testicles, which is initiated by the pituitary gland.
Testosterone concentrations begin to decline as men age for several reasons, including decreases
in the number of Leydig cells, diminishing response from the pituitary, and an increase in sex
hormone binding globulin (SHBG) (Finkelstein et al., 2013). As men age, there is an increase of
SHBG, which binds to free testosterone in the blood stream. Free testosterone is the form most
utilized by the body. As testosterone levels decline, androgen deficiencies may occur, causing
serious health issues as testosterone is used in many different processes (Matsumoto, 2003). The
specific cause of the decline in testosterone with age may be initiated by chrono-biological
factors, as well as lifestyle factors such as increased body fat gain and lack of physical activity.
Effects of testosterone therapy on muscle growth have been thoroughly investigated in
humans and animals (Dayal et al., 2005; Kenny et al., 2010; Serra et al., 2013; Storer et al.,
2008). One study investigated the effects of supra-physiologic doses of testosterone, injections of
600 mg of testosterone enanthate, on muscle size and strength in healthy men. The results show
that when combined with strength training, these supra-physiologic doses of testosterone
increase muscle size (Bhasin et al., 1996). Another investigation noted that the increase in
muscle mass is dependent on the dose of testosterone received (Storer et al., 2008).
Studies also evaluated the effects of muscle strength as related to testosterone dose
(Bhasin et al., 1996; Dayal et al., 2005; Kenny et al., 2010; Storer et al., 2008). One study
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showed that testosterone supplementation increased muscle mass but did not change muscle
strength in older men (Kenny et al., 2010). Testosterone was found to impact muscle strength
when administration occurred with greater weekly or monthly doses rather than smaller daily
doses.
Overall well-being and vitality, along with muscle size and strength, is affected by
testosterone. A study on the effects of a transdermal testosterone gel, which is applied daily,
found improvements in quality of life over a six month period with greater improvements
occurring after twelve months (Behre et al., 2012). Another study of transdermal testosterone
gel, also applied daily, concluded that the gel improves sexual function and mood as well as
other physical characteristics, such as muscle mass and strength (Wang et al., 2000). The
transdermal studies used hypogonadal men, or men who suffered from low concentrations of
testosterone. If men with normal testosterone concentrations were recruited for the same study,
the observed effects may not be the same.
Women have less circulating testosterone than men, but this hormone still plays a key
role in overall health. In women, testosterone is produced by the theca cells of the ovaries, the
adrenal glands, and tissues such as adipose and muscle (Pluchino et al., 2013). The ovaries are
responsible for 25% of testosterone production, the adrenal glands another 25%, and the
remainder from local tissue. After menopause, the ovaries are responsible for 50% of
testosterone, whereas the adrenal gland production decreases to 10% (Pluchino et al., 2013). As
women mature, testosterone levels decrease; circulating testosterone in women approximately 40
years of age is roughly half of that of women in their 20’s (Goldstat, Briganti, Tran, Wolfe, &
Davis, 2003). Both pre- and postmenopausal women experience low libido and other symptoms
due to low testosterone (Goldstat et al., 2003). Many postmenopausal women receive estrogen
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therapy but still experience symptoms that include decreased sexual desire, pleasure, and overall
well-being (S. R. Davis et al., 2008b; Goldstat et al., 2003; Shifren et al., 2000).
In women who have undergone oophorectomy and hysterectomy, treatment with
transdermal testosterone patches and estrogen improved sexual function and psychological wellbeing (Shifren et al., 2000). Transdermal testosterone patches have improved sexual function in
postmenopausal women, who are not also receiving estrogen (S. R. Davis et al., 2008b).
Premenopausal women, who have low libido and testosterone, treated with a testosterone cream,
experienced improvements in well-being, mood, and sexual function (Goldstat et al., 2003).
Although the US Food and Drug Administration has not yet approved testosterone therapy for
women, doctors have the ability to prescribe testosterone to women to counteract symptoms of
low libido and poor body composition. Hypoactive sexual desire disorder in both post- and
premenopausal women has been treated with hormone placement therapy with positive outcomes
(Goldstat et al., 2003).
Methods of Increasing Testosterone
Resistance Exercise Training
Chronic resistance exercise training has a positive effect on muscle mass and strength
(Kosek, Kim, Petrella, Cross, & Bamman, 2006), but the effect of resistance training, both acute
and chronic, on testosterone is less clear (Arazi, Damirchi, Faraji, & Rahimi, 2012; Hakkinen,
Pakarinen, Kraemer, Newton, & Alen, 2000; Weiss, Cureton, & Thompson, 1983). Research has
shown that testosterone response, due to an acute bout of heavy resistance exercise, is greater in
men than in women (Weiss et al., 1983). Testosterone response to chronic resistance exercise is
not the same as responses to acute exercise. After 6 months of heavy resistance training, neither
men nor women experienced any changes in concentrations of testosterone or growth hormone
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(Hakkinen et al., 2000). The exact mechanism for increased concentrations of testosterone is
unknown, warranting more research in this area.
Pharmaceuticals and Pro-hormones
Another method of increasing circulating testosterone is the use of pharmaceutical agents
such as transdermal testosterone patches and gels (S. R. Davis et al., 2008b; Kenny et al., 2010;
Storer et al., 2008; Wang et al., 2000). Other common methods of increasing testosterone include
mouth patches (Venkatalakshmi et al., 2012), injections (Kamischke, Venherm, Plöger, von
Eckardstein, & Nieschlag, 2001) and subcutaneous testosterone pellet implants (McCullough et
al., 2012). If men or women experience symptoms of low libido, chronic fatigue, or depression
due to low concentrations of testosterone, one of these pharmaceutical agents may be prescribed.
Testosterone pro-hormone supplements such as DHEA, androstenedione, and
androstenediol have also been marketed to increase testosterone concentrations, but research has
shown no positive outcomes with administration of these pro-hormone supplements in otherwise
healthy individuals (Brown, Vukovich, & King, 2006). These testosterone supplements, as well
as anabolic steroids, are of great interest for both bodybuilders and athletes looking to improve
muscle mass and physical performance, respectively (Arazi & Hosseini, 2011). Use or abuse of
these products for sport may be due to the lack of knowledge of adverse effects.
Nutritional Intake
Circulating testosterone can be manipulated naturally through nutritional interventions
such as alterations in macronutrient and micronutrient content of a diet. Acute changes to
macronutrient content of a meal produce little to no changes in hormone concentrations
immediately following ingestion (Alleman Jr & Bloomer, 2011). Chronic changes in
macronutrient content have shown more positive results in influencing hormonal changes
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(Hämäläinen, Adlercreutz, Puska, & Pietinen, 1984). Increasing carbohydrate intake or saturated
fat intake may produce increases in testosterone in certain individuals (Anderson et al., 1987).
Alterations of micronutrient content may produce favorable outcomes in regards to
circulating testosterone. One micronutrient associated with testosterone production is zinc. Zinc
deficiencies have been linked to low testosterone concentrations, but studies are inconclusive on
the effects of zinc magnesium aspartate, or ZMA, in relation to testosterone concentrations
(Brilla & Conte, 2000; Koehler, Parr, Geyer, Mester, & Schänzer, 2007). ZMA supplementation
may be more effective for individuals with low zinc levels. Vitamin D is another macronutrient
that is directly related to testosterone levels. Research indicates vitamin D may have positive
effects on testosterone levels (Pilz et al., 2011), but more trials are needed.
Herbal and Dietary Supplements
Dietary supplements and botanical agents, which are widely available on the market, may
have a positive effect in raising testosterone levels. One dietary supplement of recent interest is
D-aspartic acid (DAA) (Topo et al., 2009). One product, N-methyl-D-aspartic acid or NMDA,
combines the dietary supplement DAA with the botanical agents E. longifolia and Mucuna
pruriens to potentially increase testosterone (Willoughby, Spillane, & Schwarz, 2014). Other
botanical agents which have been investigated include Ginkgo bilboa (Ahmed, Abdel-Rahman,
Ali, & Moniem, 2009), fenugreek (Bushey et al., 2009), Tribulus terrestris (Neychev & Mitev,
2005; Qureshi, Naughton, & Petroczi, 2014b; Singh, Nair, & Gupta, 2012), Bulbine natalensis
(M. Yakubu & Afolayan, 2009; M. T. Yakubu & Afolayan, 2010), ecdysterone (Chermnykh,
Shimanovskii, Shutko, & Syrov, 1988; Wilborn et al., 2006), and shilajit (70-72). E. longifolia,
Ginkgo bilboa, fenugreek, and Tribulus terrestris have been thoroughly reviewed (72). Bulbine
natalensis, ecdystrone, Mucuna pruriens, and shilajit have shown promise in animal studies, but
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no human studies have been performed. E. longifolia is one botanical agent that has shown the
greatest potential to increase testosterone levels. The botanical agents E. longifolia and maca
root, and the amino acid DAA have shown potential and will be reviewed in more detail below.
Eurycoma Longifolia
One herbal supplement, E. longifolia, has been of great interest being researched in
animals (73-75) and humans (Hamzah & Yusof, 2003; Henkel et al., 2014; Muhamad et al.,
2009; Muhamad et al., 2010; Sarina et al., 2009; Tambi et al., 2012). E. longifolia is a tropical
plant, which grows in southwest Asian countries such as Malaysia, Indonesia, and Vietnam.
Common names for E. longifolia include Tongkat Ali, long jack root, Malaysian ginseng, and
many others. The roots of E. longifolia are of particular interest, as chemical compounds have
been extracted from the roots. These compounds have anti-tumor promoting and anti-parasitic
properties, as well as the ability to increase circulating testosterone (77). E. longifolia
commercial products are available either in the form of raw crude powder of the root, as a
capsule with other ingredients, and as an additive mixed with coffee.
In vitro experiments have examined the effects of E. longifolia on human spermatozoa
and rat testicular Leydig cells (Erasmus, Solomon, Fortuin, & Henkel, 2012; B. Low, Choi,
Wahab, Das, & Chan, 2013). Therapeutically used concentrations (<2.5 μg·ml−1) of E. longifolia
extract had no deleterious effects on sperm function, but harmful effects may be seen at very
high concentrations (B. Low et al., 2013). Rat Leydig cells incubated with Eurycomanone, a
quassinoid found in the root extract of E. longifolia, for two hours experienced dose dependent
increases in testosterone production. Inhibiting aromatase conversion of testosterone to estrogen
brought about the increase in testosterone production (S. M. Talbott, Talbott, George, & Pugh,
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2013). Phosphodiesterase inhibition was seen at the higher concentration (S. M. Talbott et al.,
2013).
Animal studies show that E. longifolia can enhance libido and sexual motivation in male
rats (Ang & Sim, 1997, 1998). One study used 240 sexually experienced male rats, as the male
rats were housed in a cage with a non-experimental female. The rats were treated with fractions
of E. longifolia: 200, 400, and 800 mg/kg body weight twice daily. The results showed a positive
correlation between mounting frequency and dose of E. longifolia (Ang & Sim, 1997). Another
study employed 260 sexually naïve male rats and were treated at the same fractions of the
previous study. The results showed E. longifolia enhanced crossovers and mountings (Ang &
Sim, 1998), but there were no differences between fractions as found in previous research. These
two studies support the claimed aphrodisiac qualities of E. longifolia.
A pilot study examined the effects of E. longifolia on body composition, muscle size, and
muscle strength in fourteen healthy men (Hamzah & Yusof, 2003). For five weeks, subjects
performed an intense strength training program while ingesting 100 mg/day of an E. longifolia
water soluble extract or a placebo. The results showed a significant decrease in body fat for both
groups. The increases in lean body mass, arm circumference and strength were significant in the
treatment group but not the placebo group. These results show that supplementation of E.
longifolia has favorable outcomes for body composition, muscle size, and muscle strength when
combined with a strength training program.
A recent study examined the ergogenic effects of E. longifolia had on an elderly
population, 13 male and 12 female subjects aged 57-72 years and physically active (Henkel et
al., 2014). Subjects were treated with a 400 mg E. longifolia supplement daily for 5 weeks, and
concentrations of total and free testosterone, DHEA, cortisol, insulin-like growth factor-1, and
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SHBG were analyzed. Additional biochemical parameters were taken and muscle strength was
determined by a hand grip test. Results showed treatment with a 400 mg dose of E. longifolia
significantly increases total and free testosterone concentrations and muscle strength followed a
similar trend. In women, free testosterone rose from 0.50 ± 0.24 pg/mL to 1.11 ± 0.66 pg/mL.
Muscle strength in women increased from 29.61 ± 7.28 kg to 33.67 ± 8.38 kg. In men, free
testosterone increased from 5.20 ± 1.60 pg/mL to 8.38 ± 2.18 pg/mL. Muscular strength in men
increased from 46.03 ± 11.30 kg to 53.67 ± 9.86 kg. SHBG concentrations declined significantly
in women (59.66 ± 17.18 nmol/L to 47.26 ± 16.65 nmol/L), possibly affecting the increase in free
testosterone (Henkel et al., 2014)
Another recent experiment examined the effects of E. longifolia on stress hormones and
mood in subjects who were moderately stressed. A total of 63 subjects (32 men and 31 women)
with moderate stress ingested an E. longifolia root extract (200 mg/day) or placebo for 4 weeks
(S. Talbott et al., 2006). Improvements in subjective feelings of tension (-11%), anger (-12%)
and confusion (15%) were observed in the supplement group. The supplement group also
experienced a significant decrease in cortisol levels (-16%) and a concomitant increase in
testosterone levels (+37%). These results support other findings in which daily supplementation
of E. longifolia can increase testosterone levels and improve subjective feelings (S. Talbott et al.,
2006).
Similar findings were seen on stress hormones when E. longifolia was consumed prior to
a bout of endurance exercise. Thirty male subjects consumed 100mg of E. longifolia or a placebo
30 mins prior to a mountain biking event (B. S. Low, Ng, Choy, Yuen, & Chan, 2005). Cortisol
levels were significantly lower in the supplement group (0.552 ± 0.665 μg/dL) when compared
to the placebo group (0.816 ± 0.775 μg/dL). Testosterone levels were significantly higher in the
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supplement group (86.72 ± 40.9 pg/mL) than the placebo group (72.47 ± 33.77 pg/mL).
Researchers concluded that even during intense exercise, E. longifolia might help maintain an
anabolic hormone state. However, when examining the ergogenic effects of E. longifolia on
endurance running capacity in 12 healthy male recreational athletes (Muhamad et al., 2010),
endurance running capacity was not affected by the supplementation of E. longifolia (two 75 mg
capsules twice per day) for seven days. Discrepancies in findings may be in part due to the
difference in dosing across studies, as well as the concentration of the E. longifolia supplied in
the supplement.
One explanation for the increase in testosterone and spermatogenesis with
supplementation of E. longifolia is the presence of eurycomanone, a major quassinoid present in
E. longifolia root extract. Unfortunately, E. longifolia has low bioavailability when ingested
orally as compared to intravenous administration (Shin, Lee, Yang, Lim, & Ernst, 2010).
Decreased levels of SHBG may be another reason for increasing testosterone values. As
mentioned earlier, Henkel et al. found that concentrations of SHBG decreased with E. longifolia
supplementation, which may have impacted the increase in testosterone (Henkel et al., 2014).
Eurypeptides may also exhibit an effect on biosynthesis of testosterone (Tambi et al., 2012).
Eurypeptides are bioactive compounds consisting of large chain amino acids found within the
root extract. Eurypeptides activates the CYP17 enzyme to increase the metabolism of
pregnenolone and 17-OH-pregnenolone to yield more dehyodroepiandrosterone. Metabolism of
progesterone and 17-OH-progestrone to 4-androstenedione and to testosterone is also increased
(Tambi et al., 2012). With these identified mechanisms and with more work documenting the
benefit of E. longifolia, it may become a viable alternative to testosterone replacement therapy.

48

Maca Root
Maca, or Lepidium meyenii, is a plant indigenous to the Andes Mountains, and extracts of
the root have been used to improve sexual function for centuries (G. F. Gonzales, Ruiz,
Gonzales, Villegas, & Cordova, 2001). In controlled studies, maca root has been used to treat
sexual dysfunction in humans and animals. Phytosterols or phytoestrogens, which are two
compounds found in maca, may be the mechanism for improving sexual function (G. F.
Gonzales et al., 2001). Maca is commercially available in stores and online in different forms,
such as tablets.
Maca root supplementation has been examined in both rats and mice with favorable
outcomes (Zheng et al., 2000). In normal mice, maca (orally administered for 22 days)
significantly increases libido and sexual potency (Zheng et al., 2000). One-time oral
administration in mice showed that the active ingredients were immediately bioavailable. Maca
also improved erectile function and the latent period of erection in rats with erectile dysfunction
and with removed testes, respectively (Zheng et al., 2000). Other experiments with rats have also
reported aphrodisiac effects with maca administration (G. Gonzales et al., 2002).
The aphrodisiac properties of maca have been shown in healthy men as well as men with
mild erectile dysfunction. Healthy men were administered 1.5g or 3g of maca and the effects on
sexual desire, mood, and serum testosterone were measured at 4, 8, and 12 weeks (Zenico,
Cicero, Valmorri, Mercuriali, & Bercovich, 2009). Of the men administered maca, 42.2%
experienced an increase in sexual desire after 12 weeks of supplementation (Zenico et al., 2009).
However, serum testosterone and scores of depression and anxiety were not changed with
treatment. In addition, men with mild erectile dysfunction experienced an increase in sexual
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desire as well as an increase in quality of life with administration of maca (2400mg/day for 12
weeks) (Zenico et al., 2009).
Another study has shown that both men and women experience improvements in sexual
desire with supplementation of maca. A total of 3 Men and 17 women with selective-serotonin
reuptake inhibitor (SSRI)-induced sexual dysfunction ingested either 1.5g or 3g of maca per day
for 12 weeks with assessments of sexual function and depression being made every 2 weeks
(Brooks et al., 2008). There was a significant increase in libido in the supplement groups, with
the higher dose group having a greater improvement. There was also a downward trend seen in
depression scores over the course of supplementation, which may be attributed to the increases in
libido. These results may be more generalizable to women than men, as women made up 85% of
the subject pool.
Postmenopausal women were treated with 3.5g per day of powdered maca and
assessments were made at the end of supplementation of psychological symptoms, sexual
dysfunction, and hormone concentrations (D'Aniello et al., 1996). Maca supplementation
reduced sexual dysfunction and improved psychological symptoms. No differences were seen in
serum concentrations of estradiol, follicle-stimulating hormone, luteinizing hormone, and SHBG
between groups. These data add to other findings supporting maca root as an aphrodisiac.
D-aspartic acid
One dietary supplement, DAA, has been marketed and researched for its ability to
increase testosterone levels. DAA occurs naturally in animals and appears to be able to stimulate
the release of sex hormones from the pituitary and testes. Early in vitro experiments, where DAA
was introduced to isolated rat testes, have shown DAA can activate synthesis of testosterone
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(D'Aniello et al., 1996). Studies employing male rats have demonstrated the involvement of
DAA in steroidogenesis (Nagata, Homma, Lee, & Imai, 1999; Topo et al., 2009).
Human studies involving DAA supplementation have found conflicting evidence on the
effects of DAA on circulating testosterone. The first human study found that DAA
supplementation significantly increased testosterone levels when compared to the placebo (Topo
et al., 2009). Twenty-three healthy male subjects (27 to 37 years of age) received a 10 ml 2.0 M
solution of sodium D-aspartate solution to be taken in the morning for 12 days, while 20 other
males received a placebo. Levels of testosterone and luteinizing hormone were monitored after 6
and 12 day of supplementation and again 3 days after the cessation of treatment. At 12 days of
supplementation, 20 of 23 subjects in the experimental group had increased concentrations of
luteinizing hormone and testosterone. Researchers concluded DAA plays a role in the release and
synthesis of testosterone and luteinizing hormone (Topo et al., 2009).
A more recent human study evaluated the influence of DAA on circulating testosterone
(Willoughby & Leutholtz, 2013). In this randomized, double-blind manner, 20 healthy,
recreationally active, resistance trained men (~23 years of age) took part in 28 days of heavy
resistance training while ingesting 3 grams of DAA or placebo daily. Assessments of body
composition, muscle strength, and serum hormones (total and free testosterone, luteinizing
hormone, estrogen, and gonadotropin-releasing hormone) were made on day 0 and day 29. These
results show there were similar gains in muscle mass and strength in both groups. Contrary to
previous research, this study did not find any effects of DAA supplementation on testosterone
levels. The differences these findings may be due to the age differences in subject’s age and
training status, as well as different baseline testosterone values.
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Another recent study examined the effects of a DAA supplement on blood testosterone,
along with subjective measures of health indicators (Bloomer, Gunnels, Moran, & Schriefer, ).
Ten overweight or obese men (mean age of 42 years) were assigned to groups where one group
ingested one severing per day and the other ingested two servings per day of the supplement.
One serving of the supplement contained 3120mg of DAA, 480mg of sodium nitrate, and
4000IU of vitamin D. After the supplementation period, subjects experienced an increase in
subjective feeling of vitality and libido (Bloomer et al.). Testosterone values were impacted in
subjects with low basal testosterone levels, but the impact was not seen in men with higher
testosterone levels. DAA supplements may have positive outcome on testosterone concentrations
if starting testosterone levels are low.
Conclusion
Maintaining normal levels of testosterone may provide several benefits for men and
women of all ages. If testosterone levels are low, undesired effects may be seen in body
composition, overall health and well-being. Pharmaceutical agents, dietary supplements, and
herbal supplements have been used to remedy low testosterone concentrations and associated
health related issues with moderate success. Common symptoms of low testosterone seen in men
and women include low libido, chronic fatigue, and a decrease in overall well-being.
These symptoms may be treated with testosterone replacement therapy with
pharmaceutical drugs such as transdermal testosterone patches or gels, injections, and implants.
The use of dietary or herbal supplements instead of drugs may be used as an alternative to
testosterone replacement therapy. DAA is one dietary supplement of great interest as it has
shown to increase testosterone in some men, mainly those with low concentrations of
testosterone. A daily dose of 3g of DAA may be enough to increase testosterone concentrations
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in some men. More human research is warranted to determine the most effective dose and
treatment period of DAA to raise testosterone levels. There is evidence for the use of E.
longifolia, an herbal supplement, to elevate circulating testosterone and improve libido in men
and women. While a 100mg/day dose of E. longifolia has been ineffective in raising testosterone
levels, a 200mg/day dose has been shown to increase circulating testosterone. There is also
evidence that maca root improves sexual desires, but it does not appear to have an effect on
circulating testosterone. Effective doses of maca may be 1.5g or 3g per day. These herbal and
dietary supplements may be effective in improving sexual desire and overall quality of life and
require additional research.
Literature Gaps and Limitations
It appears that both women and men can benefit from testosterone replacement therapy. Both
postmenopausal and premenopausal women with low basal testosterone have experienced
increases in overall well-being, mood, and sexual function from testosterone replacement
therapy. It is also possible that women may benefit in a similar manner as men from dietary or
herbal supplementation. There is a need for a study to evaluate the use of botanical agents in
women, as supplementation may elevate circulating testosterone and improve associated
measures of sexual health and vitality. One study has shown how supplementation of E.
longifolia in older women can increase testosterone, as well as muscle size and muscle strength
(Henkel et al., 2014). Another study has shown that maca supplementation in postmenopausal
women leads to improvements in mood and libido (Brooks et al., 2008).
Future research of botanical supplementation should focus on the population of
premenopausal women suffering from low sexual desire. A proposed study would evaluate the
ability of E. longifolia (400mg/day) to improve perceived quality of life and libido. Maca root
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supplementation (1.5g to 3g/day) may also promote positive changes in subjective feelings of
mood in this population. Another potential study would evaluate the effects of a combination of
E. longifolia and maca, which may produce greater change in subjective feeling than one herbal
agent alone.
Research Question and Hypothesis
The following research questions and hypothesis were formed based on current literature
findings.
Question 1.
Does supplementation of E. Longifolia in combination with maca root by premenopausal
women with hypoactive sexual desire disorder induce positive changes in the scores of the
psychological general well-being index, the brief profile of female sexual function, and within a
self-reported daily diary?
Question 2.
Does supplementation of E. Longifolia in combination with maca root by premenopausal
women with hypoactive sexual desire disorder induce changes in muscular strength and
endurance?
We hypothesize that supplementation of E. longifolia in combination with maca root by
premenopausal women with hypoactive sexual desire disorder will improve subjective feelings
such as mood, libido, and overall quality of life. A potential elevation in testosterone may be
associated with an increase muscular strength and endurance. This novel approach to treating
hypoactive sexual disorder may prove to be an alternative to the traditional pharmaceutical
treatment.
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